TEMN:SIXTemenos AG Analysis
Data as of 2026-09-01 - not real-time
CHF 73.85
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Temenos AG is neutral at CHF 73.85, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 9.6%. With RSI at 55.6 the momentum picture is neutral, alongside a bearish MACD signal. Watch CHF 67.85 as support and CHF 77.40 as the nearer resistance level.
Multiples put this in fair territory: 21.9 times earnings against the sector's 35.8. Sell-side targets cluster 8.7% above the current quote. The 1.86% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 36.2%, a beta of 0.18 and a maximum drawdown of 27.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Multiples put this in fair territory: 21.9 times earnings against the sector's 35.8. Sell-side targets cluster 8.7% above the current quote. The 1.86% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 36.2%, a beta of 0.18 and a maximum drawdown of 27.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 71.68
- MACD momentum is negative
- 30-day price change of +9.6%
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- P/E of 21.9 versus sector average of 35.8
- Trading above the 200-day average of 71.68
- Analyst targets imply +8.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 21.9 versus sector average of 35.8
- Analyst targets imply +8.7% versus the current price
- Profit margin of 17.5% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-1.40%
Profit Margin17.50%
P/E Ratio21.9
ROE42.80%
ROA7.54%
Debt/Equity226.40
P/B Ratio16.2
Op. Cash FlowCHF391.8M
Free Cash FlowCHF221.9M
Industry P/E35.8
Technical Analysis
TrendNeutral
RSI55.6
SupportCHF 67.85
ResistanceCHF 77.40
MA 20CHF 73.44
MA 50CHF 69.96
MA 200CHF 71.68
MACDBearish
VolumeDecreasing
Fear & Greed Index93.04
Valuation
Fair ValueCHF 31.68
Target PriceCHF 80.30
Upside/Downside8.74%
GradeFair
TypeBlend
Dividend Yield1.86%
Risk Assessment
Beta0.18
Volatility36.20%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.